Trial Profile
Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients With Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2018
Price :
$35
*
At a glance
- Drugs AGM 1470 (Primary) ; Gemcitabine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 09 Nov 2018 New trial record